RPS27 Antibody | CSB-PA020419ESR1HU

(No reviews yet) Write a Review
SKU:
CSB-PA020419ESR1HU
Availability:
3 to 7 Working Days
  • RPS27 Antibody
  • Western blot<br />
 All lanes: RPS27antibody at 2.76µg/ml<br />
 Lane 1: Mouse liver tissue<br />
 Lane 2: MCF-7 whole cell lysate<br />
 Secondary<br />
 Goat polyclonal to rabbit IgG at 1/10000 dilution<br />
 Predicted band size: 9 kDa<br />
 Observed band size: 9 kDa<br />
  • Immunohistochemistry of paraffin-embedded human brain tissue using CSB-PA020419ESR1HU at dilution of 1:100
  • Immunohistochemistry of paraffin-embedded human endometrial cancer using CSB-PA020419ESR1HU at dilution of 1:100
€230.00 - €317.10

Description

RPS27 Antibody | CSB-PA020419ESR1HU | Cusabio

RPS27 Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: RPS27

Aliases: 40S ribosomal protein S27 (Metallopan-stimulin 1) (MPS-1) (Small ribosomal subunit protein eS27), RPS27, MPS1

Background: cytosol, cytosolic small ribosomal subunit, nucleoplasm, nucleus, ribosome, DNA binding, poly (A) RNA binding, structural constituent of ribosome, zinc ion binding, cell proliferation

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: P42677

Host Species: Rabbit

Species Reactivity: Human, Mouse

Immunogen: Recombinant Human 40S ribosomal protein S27 protein (1-84AA)

Immunogen Species: Human

Applications: ELISA, WB, IHC

Tested Applications: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

Purification Method: Antigen Affinity Purified

Dilution Ratio1: ELISA:1:2000-1:10000

Dilution Ratio2: WB:1:1000-1:5000

Dilution Ratio3: IHC:1:20-1:200

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Others

Research Areas: Others

View AllClose

0 Reviews

View AllClose